What are the major opportunities in the Huntington’s Disease Treatment market? What are the strategies for the Huntington’s Disease Treatment market?

For detailed insights on the major opportunities and strategies in the Huntington’s Disease Treatment market, Read More

How does the Huntington’s Disease Treatment market relate to the overall economy and other similar markets?

For detailed insights on Huntington’s Disease Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Huntington’s Disease Treatment market growth? SWOT analysis of the Huntington’s Disease Treatment market.

For detailed insights on the key dynamics influencing the Huntington’s Disease Treatment market growth and SWOT analysis of the Huntington’s Disease Treatment industry, Read More

Global Huntington’s Disease Treatment Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Huntington’s Disease Treatment Global Market Report 2025

Name: Huntington’s Disease Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment (Symptomatic Treatment, Disease-Modifying Therapies), By Administration Type (Oral, Intravenous, Subcutaneous, Topical), By Therapeutic (Genetic Disorders, Neurological Disorders, Psychiatric Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Homecare Settings, Research Centers) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Huntington’s Disease Treatment Market Overview

• Huntington’s Disease Treatment market size has reached to $0.73 billion in 2024

• Expected to grow to $1.32 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%

• Growth Driver: The Increase In Gene Therapies Is Fueling The Growth Of The Market Due To Their Ability To Target Genetic Causes And Slow Disease Progression

• Market Trend: Advancements In Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Therapies For Huntington's Disease Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Huntington’s Disease Treatment Market?

Huntington’s disease treatment involves medical therapies designed to manage the symptoms of this progressive neurological disorder. The primary goal is to slow disease progression, alleviate symptoms, and enhance the patient’s quality of life.

The main types of Huntington’s disease treatment are symptomatic treatment and disease-modifying therapies. Symptomatic treatment focuses on alleviating Huntington’s disease symptoms and improving quality of life without addressing the underlying cause, and is increasingly in demand as patients seek better management of daily challenges. These treatments can be administered through various methods, including oral, intravenous, subcutaneous, and topical routes for various therapeutic applications, including genetic, neurological, and psychiatric disorders. The treatments are distributed through multiple channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by a range of end users, including hospitals, clinics, home care settings, and research institutions.

Huntington’s Disease Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Huntington’s Disease Treatment Market Size 2025 And Growth Rate?

What Is The Huntington’s Disease Treatment Market Growth Forecast?

The Huntington’s disease treatment market size is expected to see rapid growth in the next few years. It will grow to $1.32 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to a growing focus on personalized medicine, increasing integration of digital health monitoring, increasing regulatory support for orphan drugs, rising demand for symptomatic relief therapies, and growing demand for disease-modifying treatments. Major trends in the forecast period include technology-driven gene silencing tools, developing cell-based therapies, developing peripheral biomarkers, integration of telehealth in HD care, integration of patient-reported outcomes, and innovation in disease-modifying drugs.

The forecast of 12.6% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade barriers may impact U.S. neurology centers by increasing prices of tetrabenazine formulations and genetic testing kits imported from Canada and Italy, delaying symptomatic treatment initiation and raising rare neurodegenerative disease care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Huntington’s Disease Treatment Market Segmented?

1) By Treatment: Symptomatic Treatment, Disease-Modifying Therapies

2) By Administration Type: Oral, Intravenous, Subcutaneous, Topical

3) By Therapeutic: Genetic Disorders, Neurological Disorders, Psychiatric Disorders

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Homecare Settings, Research Centers

Subsegments

1) By Symptomatic Treatment: antidepressants, Antipsychotics, Mood Stabilizers, Chorea Medications, Cognitive Enhancers

2) By Disease-Modifying Therapies: Gene Therapy, Neuroprotective Agents, RNA-Based Therapies, stem cell therapy, Protein-Targeting Therapies

What Is Driving The Huntington’s Disease Treatment Market? The Increase In Gene Therapies Is Fueling The Growth Of The Market Due To Their Ability To Target Genetic Causes And Slow Disease Progression

The increase in gene therapies is expected to propel the growth of the Huntington’s disease treatment market going forward. Gene therapies are treatments that modify or replace faulty genes to cure or prevent diseases at the genetic level. Gene therapies are growing as precision medicine advances, enabling direct targeting of genetic causes and achieving better outcomes than traditional treatments. Gene therapies treat Huntington’s disease by silencing the defective HTT gene that generates harmful proteins, preventing nerve cell damage. This strategy helps slow disease progression, protect brain function, and offers potential for long-term control. For instance, in July 2023, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drugs and devices, at the end of Q1 2023, there were 247 gene therapies in phase II, but this number rose by 5% to reach 260 by the end of Q2. Therefore, the increase in gene therapies is driving the growth of the Huntington’s disease treatment industry.

Who Are The Major Players In The Global Huntington’s Disease Treatment Market?

Major companies operating in the huntington’s disease treatment market are F. Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Bausch Health Companies Inc., Sun Pharmaceutical Industries Inc., H. Lundbeck A/S, WaVe Life Sciences Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Annexon Inc., Uniqure NV, Sage Therapeutics Inc., Azevan Pharmaceuticals Inc., Prilenia Therapeutics B.V.

What Are The Key Trends Of The Global Huntington’s Disease Treatment Market? Advancements In Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Therapies For Huntington's Disease Treatment

Major companies operating in the Huntington’s disease treatment market are focused on developing advanced therapies such as selective vesicular monoamine transporter 2 (VMAT2) inhibitor capsules to potentially improve patient quality of life while slowing disease progression. Selective VMAT2 inhibitor capsules are medications that block the vesicular monoamine transporter 2, a protein involved in packaging neurotransmitters for brain release. These drugs help reduce neurotransmitter release, aiding in the management of involuntary movements and related symptoms. For instance, in August 2023, Neurocrine Biosciences, Inc., a US-based biotech company, received approval from the U.S. Food and Drug Administration (FDA) for Ingrezza (valbenazine) capsules for the treatment of chorea associated with Huntington's disease (HD) in adults. These capsules are a once-daily oral VMAT2 inhibitor, working by reducing excessive dopamine signaling in the brain to help control involuntary movements. The medication is available in multiple capsule strengths and can be taken with or without food, offering a convenient dosing option for patients.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Huntington’s Disease Treatment Market? PTC Therapeutics Partnered With Novartis AG To Accelerate Development Of PTC518 For Huntington's Disease

In December 2024, PTC Therapeutics Inc., a US-based pharmaceutical company that is actively developing a treatment for Huntington’s disease, partnered with Novartis AG to provide a Huntington’s disease treatment. This partnership aims to accelerate the development and global commercialization of PTC518, a potential first-in-class oral, disease-modifying therapy for Huntington’s disease. Novartis AG is a Switzerland-based manufacturer of drugs for Huntington’s disease.

What Is The Regional Outlook For The Global Huntington’s Disease Treatment Market?

North America was the largest region in the Huntington’s disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Huntington’s Disease Treatment Market?

The Huntington's disease treatment market consists of sales of products including tetrabenazine, deutetrabenazine, huntingtin-lowering therapies, cannabinoids, and cognitive enhancers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Huntington’s Disease Treatment Industry?

The huntington’s disease treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the huntington’s disease treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Huntington’s Disease Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$0.83 billion
Revenue Forecast In 2034	$1.35 billion
Growth Rate	CAGR of 13.0% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The huntington’s disease treatment market covered in this report is segmented – 1) By Treatment: Symptomatic Treatment, Disease-Modifying Therapies 2) By Administration Type: Oral, Intravenous, Subcutaneous, Topical 3) By Therapeutic: Genetic Disorders, Neurological Disorders, Psychiatric Disorders 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 5) By End-User: Hospitals, Clinics, Homecare Settings, Research Centers Subsegments 1) By Symptomatic Treatment: Antidepressants, Antipsychotics, Mood Stabilizers, Chorea Medications, Cognitive Enhancers 2) By Disease-Modifying Therapies: Gene Therapy, Neuroprotective Agents, RNA-Based Therapies, Stem Cell Therapy, Protein-Targeting Therapies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Bausch Health Companies Inc., Sun Pharmaceutical Industries Inc., H. Lundbeck A/S, WaVe Life Sciences Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Annexon Inc., Uniqure NV, Sage Therapeutics Inc., Azevan Pharmaceuticals Inc., Prilenia Therapeutics B.V.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Huntington’s Disease Treatment Market Characteristics

3. Huntington’s Disease Treatment Market Trends And Strategies

4. Huntington’s Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Huntington’s Disease Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Huntington’s Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Huntington’s Disease Treatment Market Growth Rate Analysis

5.4. Global Huntington’s Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Huntington’s Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Huntington’s Disease Treatment Total Addressable Market (TAM)

6. Huntington’s Disease Treatment Market Segmentation

6.1. Global Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Symptomatic Treatment

Disease-Modifying Therapies

6.2. Global Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Subcutaneous

Topical

6.3. Global Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Disorders

Neurological Disorders

Psychiatric Disorders

6.4. Global Huntington’s Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.5. Global Huntington’s Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Homecare Settings

Research Centers

6.6. Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antidepressants

Antipsychotics

Mood Stabilizers

Chorea Medications

Cognitive Enhancers

6.7. Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Disease-Modifying Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Neuroprotective Agents

RNA-Based Therapies

Stem Cell Therapy

Protein-Targeting Therapies

7. Huntington’s Disease Treatment Market Regional And Country Analysis

7.1. Global Huntington’s Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Huntington’s Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Huntington’s Disease Treatment Market

8.1. Asia-Pacific Huntington’s Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Huntington’s Disease Treatment Market

9.1. China Huntington’s Disease Treatment Market Overview

9.2. China Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Huntington’s Disease Treatment Market

10.1. India Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Huntington’s Disease Treatment Market

11.1. Japan Huntington’s Disease Treatment Market Overview

11.2. Japan Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Huntington’s Disease Treatment Market

12.1. Australia Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Huntington’s Disease Treatment Market

13.1. Indonesia Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Huntington’s Disease Treatment Market

14.1. South Korea Huntington’s Disease Treatment Market Overview

14.2. South Korea Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Huntington’s Disease Treatment Market

15.1. Western Europe Huntington’s Disease Treatment Market Overview

15.2. Western Europe Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Huntington’s Disease Treatment Market

16.1. UK Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Huntington’s Disease Treatment Market

17.1. Germany Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Huntington’s Disease Treatment Market

18.1. France Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Huntington’s Disease Treatment Market

19.1. Italy Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Huntington’s Disease Treatment Market

20.1. Spain Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Huntington’s Disease Treatment Market

21.1. Eastern Europe Huntington’s Disease Treatment Market Overview

21.2. Eastern Europe Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Huntington’s Disease Treatment Market

22.1. Russia Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Huntington’s Disease Treatment Market

23.1. North America Huntington’s Disease Treatment Market Overview

23.2. North America Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Huntington’s Disease Treatment Market

24.1. USA Huntington’s Disease Treatment Market Overview

24.2. USA Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Huntington’s Disease Treatment Market

25.1. Canada Huntington’s Disease Treatment Market Overview

25.2. Canada Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Huntington’s Disease Treatment Market

26.1. South America Huntington’s Disease Treatment Market Overview

26.2. South America Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Huntington’s Disease Treatment Market

27.1. Brazil Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Huntington’s Disease Treatment Market

28.1. Middle East Huntington’s Disease Treatment Market Overview

28.2. Middle East Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Huntington’s Disease Treatment Market

29.1. Africa Huntington’s Disease Treatment Market Overview

29.2. Africa Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Huntington’s Disease Treatment Market Competitive Landscape And Company Profiles

30.1. Huntington’s Disease Treatment Market Competitive Landscape

30.2. Huntington’s Disease Treatment Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Vertex Pharmaceuticals Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Huntington’s Disease Treatment Market Other Major And Innovative Companies

31.1. Sun Pharmaceutical Industries Inc.

31.2. H. Lundbeck A/S

31.3. WaVe Life Sciences Ltd.

31.4. Dr. Reddy’s Laboratories Ltd.

31.5. Hikma Pharmaceuticals plc

31.6. Lupin Limited

31.7. Neurocrine Biosciences Inc.

31.8. Alnylam Pharmaceuticals Inc.

31.9. PTC Therapeutics Inc.

31.10. Ionis Pharmaceuticals Inc.

31.11. Annexon Inc.

31.12. Uniqure NV

31.13. Sage Therapeutics Inc.

31.14. Azevan Pharmaceuticals Inc.

31.15. Prilenia Therapeutics B.V.

32. Global Huntington’s Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Huntington’s Disease Treatment Market

34. Recent Developments In The Huntington’s Disease Treatment Market

35. Huntington’s Disease Treatment Market High Potential Countries, Segments and Strategies

35.1 Huntington’s Disease Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Huntington’s Disease Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Huntington’s Disease Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Huntington’s Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Huntington’s Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Disease-Modifying Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Huntington’s Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Huntington’s Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: F. Hoffmann-La Roche Ltd. Financial Performance

Table 79: Novartis AG Financial Performance

Table 80: Teva Pharmaceutical Industries Ltd. Financial Performance

Table 81: Vertex Pharmaceuticals Incorporated Financial Performance

Table 82: Bausch Health Companies Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Huntington’s Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Huntington’s Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Disease-Modifying Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Huntington’s Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Huntington’s Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 79: Novartis AG Financial Performance

Figure 80: Teva Pharmaceutical Industries Ltd. Financial Performance

Figure 81: Vertex Pharmaceuticals Incorporated Financial Performance

Figure 82: Bausch Health Companies Inc. Financial Performance

2025 Over-The-Counter (OTC) Diet Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Parathyroid Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Industry Forecast: PCSK9 Inhibitor Market to Generate $6.87 Billion Revenue by 2029

CAGR of 5.4% Projected for Pediatric Asthma Treatment Market From 2025 to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Brain Monitoring Global Market Report 2025 – By Product (Magnetoencephalograph, Electroencephalograph, Cerebral Oximeters, Functional Magnetic Resonance Imaging (fMRI), Intracranial Pressure Monitoring Devices, Other Pro...

Brain Computer Interface Global Market Report 2025 – By Type (Invasive Brain Computer Interface, Partially Invasive Brain Computer Interface, Non Invasive Brain Computer Interface, Other Types), By Component (Hardware, S...

Brain Health Supplements Global Market Report 2025 – By Product (Natural Molecules, Herbal Extract, Vitamins and Minerals), By Supplement Form (Tablets, Capsules, Liquid), By Distribution (Supermarket and Hypermarket, Dr...

Non-Invasive Brain Trauma Monitoring Devices Global Market Report 2025 – By Type( Non-invasive Intracranial Pressure Monitor, Non-invasive Cerebral Edema Dynamic Monitor, Other Types), By Application( Cardiology, Urology...

Deep Brain Stimulation Device Global Market Report 2025 – By Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), By Application (Epilepsy, Essential Tremor, Obsessive-Compulsive Disor...

Brain Tumor Drugs Global Market Report 2025 – By Drugs (Temozolomide, Bevacizumab, Other Drugs), By End User (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other End-Users) – Impact of Tariff and Trade War on Marke...

Brain And Neuroimaging Devices Global Market Report 2025 – By Imaging Type (Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magnet...

Frequently Asked Questions

What is the definition of the Huntington’s Disease Treatment market?

How will the Huntington’s Disease Treatment market drivers and restraints affect the market dynamics? What forces will shape the Huntington’s Disease Treatment industry going forward?

The market major growth driver - The Increase In Gene Therapies Is Fueling The Growth Of The Market Due To Their Ability To Target Genetic Causes And Slow Disease Progression. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Huntington’s Disease Treatment market?

The Huntington’s disease treatment market size has grown rapidly in recent years. It will grow from $0.73 billion in 2024 to $0.82 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing awareness of genetic disorders, growing genetic testing accessibility, growing investment in neurodegenerative disease research, a rising number of clinical trials for experimental therapies, and a growing pipeline of disease-modifying drugs. The Huntington’s disease treatment market size is expected to see rapid growth in the next few years. It will grow to " $1.32 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to a growing focus on personalized medicine, increasing integration of digital health monitoring, increasing regulatory support for orphan drugs, rising demand for symptomatic relief therapies, and growing demand for disease-modifying treatments. Major trends in the forecast period include technology-driven gene silencing tools, developing cell-based therapies, developing peripheral biomarkers, integration of telehealth in HD care, integration of patient-reported outcomes, and innovation in disease-modifying drugs. For further insights on this market, request a sample here

How is the Huntington’s Disease Treatment market segmented?

The huntington’s disease treatment market covered in this report is segmented –
1) By Treatment: Symptomatic Treatment, Disease-Modifying Therapies
2) By Administration Type: Oral, Intravenous, Subcutaneous, Topical
3) By Therapeutic: Genetic Disorders, Neurological Disorders, Psychiatric Disorders
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Homecare Settings, Research Centers Subsegments:
1) By Symptomatic Treatment: Antidepressants, Antipsychotics, Mood Stabilizers, Chorea Medications, Cognitive Enhancers
2) By Disease-Modifying Therapies: Gene Therapy, Neuroprotective Agents, RNA-Based Therapies, Stem Cell Therapy, Protein-Targeting Therapies For further insights on this market, request a sample here

Which region has the largest share of the Huntington’s Disease Treatment market? What are the other regions covered in the report?

North America was the largest region in the Huntington’s disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the huntington’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Huntington’s Disease Treatment market?

What are the key trends in the Huntington’s Disease Treatment market?

Major trends in this market include Advancements In Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Therapies For Huntington's Disease Treatment. For further insights on this market, request a sample here.